Stock Scorecard
Stock Summary for Merck & Co Inc (MRK) - $118.41 as of 9/6/2024 4:00:18 PM EST
Total Score
14 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for MRK
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MRK
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MRK
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MRK
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Financial Details for MRK
Company Overview |
|
---|---|
Ticker | MRK |
Company Name | Merck & Co Inc |
Country | USA |
Description | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2024 |
Next Earnings Date | 10/31/2024 |
Stock Price History |
|
Last Day Price | 118.41 |
Last Day Price Updated | 9/6/2024 4:00:18 PM EST |
Last Day Volume | 8,487,970 |
Average Daily Volume | 10,075,432 |
52-Week High | 134.63 |
52-Week Low | 97.23 |
Last Price to 52 Week Low | 21.78% |
Valuation Measures |
|
Trailing PE | 21.82 |
Industry PE | 34.82 |
Sector PE | 80.12 |
5-Year Average PE | 27.55 |
Free Cash Flow Ratio | 24.26 |
Industry Free Cash Flow Ratio | 13.19 |
Sector Free Cash Flow Ratio | 30.42 |
Current Ratio Most Recent Quarter | 1.47 |
Total Cash Per Share | 4.88 |
Book Value Per Share Most Recent Quarter | 17.19 |
Price to Book Ratio | 6.85 |
Industry Price to Book Ratio | 6.02 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 4.81 |
Industry Price to Sales Ratio Twelve Trailing Months | 7.56 |
Sector Price to Sales Ratio Twelve Trailing Months | 6.66 |
Share Statistics |
|
Total Shares Outstanding | 2,534,810,000 |
Market Capitalization | 300,146,852,100 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 9/16/2024 |
Last Dividend Amount | 0.77 |
Current Dividend Amount | 0.77 |
Total Years Dividend Increasing |
![]() |
Trailing Annual Dividend Rate | 3.81 |
Trailing Annual Dividend Yield | 3.23% |
Forward Annual Dividend Rate | 4.08 |
Forward Annual Dividend Yield | 3.46% |
5-Year Dividend Payments Count | 21 |
3-Year Average Dividend Yield | 2.89% |
5-Year Average Dividend Yield | 2.89% |
1-Year Dividend Growth Rate Percentage | 5.71% |
3-Year Dividend Growth Rate Percentage | 5.89% |
5-Year Dividend Growth Rate Percentage | 6.98% |
All-Time Dividend Growth Rate Percentage | 13.38% |
Dividend Payout Ratio | 71.08% |
Income Statement |
|
Quarterly Earnings Growth YOY | 68.50% |
Annual Earnings Growth | -97.49% |
Reported EPS 12 Trailing Months | 5.40 |
Reported EPS Past Year | 4.35 |
Reported EPS Prior Year | 1.50 |
Net Income Twelve Trailing Months | 13,736,000,000 |
Net Income Past Year | 365,000,000 |
Net Income Prior Year | 14,519,000,000 |
Quarterly Revenue Growth YOY | 7.20% |
5-Year Revenue Growth | 7.29% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 12,380,000,000 |
Total Cash Past Year | 7,857,000,000 |
Total Cash Prior Year | 13,192,000,000 |
Net Cash Position Most Recent Quarter | -22,337,000,000 |
Net Cash Position Past Year | -27,171,000,000 |
Long Term Debt Past Year | 35,028,000,000 |
Long Term Debt Prior Year | 30,454,000,000 |
Total Debt Most Recent Quarter | 34,717,000,000 |
Equity to Debt Ratio Past Year | 0.52 |
Equity to Debt Ratio Most Recent Quarter | 0.56 |
Total Stockholder Equity Past Year | 37,581,000,000 |
Total Stockholder Equity Prior Year | 45,991,000,000 |
Total Stockholder Equity Most Recent Quarter | 43,582,000,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 18,067,000,000 |
Free Cash Flow Per Share Twelve Trailing Months | 7.13 |
Free Cash Flow Past Year | 14,063,000,000 |
Free Cash Flow Prior Year | 48,500,000,000 |
Options |
|
Put/Call Ratio | 1.38 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.69 |
MACD Signal | -1.33 |
20-Day Bollinger Lower Band | 112.85 |
20-Day Bollinger Middle Band | 124.29 |
20-Day Bollinger Upper Band | 135.72 |
Beta | 0.40 |
RSI | 46.64 |
50-Day SMA | 117.53 |
150-Day SMA | 100.38 |
200-Day SMA | 92.46 |
System |
|
Modified | 9/7/2024 7:47:27 AM EST |